Shares of Allergy Therapeutics plc (LON:AGY – Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as GBX 7.50 ($0.09) and last traded at GBX 7.20 ($0.09), with a volume of 2510080 shares traded. The stock had previously closed at GBX 7 ($0.09).
Allergy Therapeutics Stock Up 2.9 %
The company’s 50 day moving average is GBX 5.75 and its two-hundred day moving average is GBX 5.12. The company has a market capitalization of £343.44 million, a PE ratio of -120.00, a PEG ratio of -30.70 and a beta of 1.40. The company has a quick ratio of 1.48, a current ratio of 1.40 and a debt-to-equity ratio of 37.22.
About Allergy Therapeutics
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Read More
- Five stocks we like better than Allergy Therapeutics
- What is a Dividend King?
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- How to Calculate Return on Investment (ROI)
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Airline Stocks – Top Airline Stocks to Buy Now
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
